Skip to content

Clinical trials

Bipolar Disorder trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Country / region: Spain Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20045
20053
20061
20073
20082
20092
20103
20111
20121
20132
20144
20165
20184
20193
20201
20211
20222
20232
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Unknown status8
Not yet recruiting1
Active, not recruiting1
Suspended1
Terminated1
Recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Hospital Clinic of Barcelona6
Consorcio Centro de Investigación Biomédica en Red (CIBER)4
FIDMAG Germanes Hospitalàries2
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
AB Biotics, SA1
Alcediag1
Bioaraba Health Research Institute1
Centro de Investigación Biomédica en Red de Salud Mental1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder50
Schizophrenia13
Mental Disorders6
Psychotic Disorders5
Major Depressive Disorder3
Personality Disorders3
Attention Deficit Disorder with Hyperactivity2
Bipolar and Related Disorders2
Mood Disorders2
Alzheimer Disease1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.